Unknown

Dataset Information

The Antidepressant Effect of Ketamine Is Dampened by Concomitant Benzodiazepine Medication.


ABSTRACT: The rapid antidepressant effect of ketamine has become a breakthrough in the research and treatment of depression. Although predictive and modulating factors of the response to ketamine are broadly studied, little is known about optimal concurrent medication protocols. Concerning gamma-aminobutyric acid neurotransmission being a shared target for both ketamine and benzodiazepines (BZD), we evaluated the influence of BZD on the antidepressant effect of a single ketamine infusion in depressed patients. Data from 47 patients (27 females) with major depression (MADRS ≥ 20, ≥ 1 prior nonresponse to antidepressant treatment in current episode) who participated in two previous studies (EudraCT Number: 2009-010625-39 and 2013-000952-17) entered the analysis. All of the subjects were given an infus

SUBMITTER: Andrashko V 

PROVIDER: S-EPMC7485124 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature